Eli Lilly (NYSE: LLY) began a roll in late 2020 that lasted almost four years. During that time, it became the world's largest healthcare company, with a market cap that topped $860 billion at one ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

Through Operation Warp Speed, the Trump administration effort to speed up treatments and vaccines, the government has bought 300,000 doses each from Eli Lilly and Regeneron at a cost of about ...

At a Cabinet meeting earlier this month, Trump said that he expected pharmaceutical tariffs to grow as high as 200% after ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...

E arly last year, Eli Lilly temporarily halted contributions made to members of Congress who voted against certifying the 2020 presidential election results and promoted the “violence or ...

Trump on Tuesday predicted that he could strike “two or three” trade deals with countries before implementing his so-called ...

After posting a double beat for Q2 2025, J&J (NYSE:JNJ), the pharma sector’s bellwether for the earnings season, added ~6% on ...

Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products in the U.S., they still import some drugs and ingredients used in the products. Steep pharmaceutical tariffs ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

President Donald Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month and that levies on semiconductors could come soon as well, suggesting that those import ...